Zydus Lifesciences Limited

₹1,198As of Sun 8 Nov 2026, 12:00 UTC
NSE:ZYDUSLIFEHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 11.96%
Div yield 0.08%
ROE 14.72%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM 28.64
TSR TTM 23.04%
Mkt cap ₹1.195T
ROIC 10.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,210
1.01%
24.00%
Hold 10|12|11|10|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
12.81
12.26
13.39
13.63
4.18%
2.14%
10.05%
17.20%
Revenue₹B
79.08
77.64
77.12
74.94
8.57%
1.09%
(3.34%)
(5.57%)
Peers (US$12.72B)
Cap (US$)
PE
13.46B
94.44x
12.14B
39.36x
Capital
TTM
5Y
10Y
Leveragex
2.968
2.536
2.631
EBIT/Intx
0.133
0.290
0.235
Own earn%
(437.41)
70.29
60.43
Sh yield%
30.59
27.27
27.99
Owners
Insiders/Inst%
1.94
46.71
Short interest%
3.39
SBC / revenue%
5.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–3
$1 testx
0.3
Incr. ROIC%
1